Radiopharmaceuticals

预约门诊
打印

行此手术的医生

编辑搜索过滤条件
close

缩小搜索范围

  1. 未找到姓氏以该字母开头的医生 A
  2. 查找姓氏以该字母开头的医生 B
  3. 未找到姓氏以该字母开头的医生 C
  4. 查找姓氏以该字母开头的医生 D
  5. 未找到姓氏以该字母开头的医生 E
  6. 未找到姓氏以该字母开头的医生 F
  7. 查找姓氏以该字母开头的医生 G
  8. 未找到姓氏以该字母开头的医生 H
  9. 未找到姓氏以该字母开头的医生 I
  10. 查找姓氏以该字母开头的医生 J
  11. 查找姓氏以该字母开头的医生 K
  12. 查找姓氏以该字母开头的医生 L
  13. 查找姓氏以该字母开头的医生 M
  14. 查找姓氏以该字母开头的医生 N
  15. 未找到姓氏以该字母开头的医生 O
  16. 主动 查找姓氏以该字母开头的医生 P
  17. 未找到姓氏以该字母开头的医生 Q
  18. 未找到姓氏以该字母开头的医生 R
  19. 查找姓氏以该字母开头的医生 S
  20. 查找姓氏以该字母开头的医生 T
  21. 未找到姓氏以该字母开头的医生 U
  22. 未找到姓氏以该字母开头的医生 V
  23. 查找姓氏以该字母开头的医生 W
  24. 未找到姓氏以该字母开头的医生 X
  25. 未找到姓氏以该字母开头的医生 Y
  26. 未找到姓氏以该字母开头的医生 Z
重置所有过滤器

显示$起始范围 - $结束范围/源自可用$可用医生

姓氏首字母: P

  1. Annie T. Packard, M.D.

    Annie T. Packard, M.D.

    1. Rochester, MN
    擅长领域：

    Kidney biopsy, Radiopharmaceutical therapy

研究

Doctors and scientists at Mayo Clinic are studying new radiopharmaceuticals to improve diagnosis and treatment of many diseases and conditions.

Radiopharmaceutical therapy is an active area of cancer research. These studies are conducted in coordination with Mayo Clinic Comprehensive Cancer Center. Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center. This designation recognizes the institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.

Publications

See a list of publications about radiopharmaceuticals by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.

来自妙佑医疗国际员工

在 Mayo Clinic 治疗

申请预约
关于在 Mayo Clinic 治疗
Aug. 23, 2025
打印
  1. General nuclear medicine. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/gennuclear. Accessed June 25, 2025.
  2. What is nuclear medicine and molecular imaging? Society of Nuclear Medicine & Molecular Imaging. https://snmmi.org/Patients/Patients/Fact-Sheets/What-is-Nuclear-Medicine-and-Molecular-Imaging.aspx. Accessed June 25, 2025.
  3. About nuclear medicine and molecular imaging. Society of Nuclear Medicine & Molecular Imaging. https://snmmi.org/Web/About/About-Nuclear-Medicine-and-Medical-Imaging. Accessed June 25, 2025.
  4. Lapi SE, et al. Recent advances and impending challenges for the radiopharmaceutical sciences in oncology. The Lancet Oncology. 2024; doi:10.1016/S1470-2045(24)00030-5.
  5. O'Malley JP, et al., eds. Nuclear Medicine and Molecular Imaging: The Requisites. 5th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed May 13, 2025.
  6. Mititelu MR, et al. Overview of adverse reactions of radiopharmaceuticals. Clinical Oncology. 2025; doi:10.1016/j.clon.2025.103857.
  7. Bone scan. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/bone-scan. Accessed June 25, 2025.
  8. Hepatobiliary nuclear medicine. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/hepatobiliary. Accessed June 25, 2025.
  9. Scintimammography. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/scintimammo. Accessed June 25, 2025.
  10. Townsend CM Jr, et al. The parathyroid glands. In: Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 21st ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed July 11, 2025.
  11. Pylarify (prescribing information). Progenics Pharmaceuticals; 2023. https://www.pylarify.com. Accessed July 11, 2025.
  12. Kit for the preparation of technetium Tc 99m mertiatide injection (prescribing information). Jubilant Radiopharma; 2023. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216820. Accessed July 11, 2025.
  13. Fact sheet: Molecular imaging and the brain. Society of Nuclear Medicine & Molecular Imaging. https://snmmi.org/Patients/Patients/Fact-Sheets/Molecular-Imaging-and-the-Brain.aspx. Accessed June 25, 2025.
  14. Lymphoscintigraphy. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/lympho. Accessed June 25, 2025.
  15. Thyroid scan and uptake. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/thyroiduptake. Accessed June 25, 2025.
  16. Zevalin (prescribing information). Spectrum Pharmaceuticals; 2018. http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=125019. Accessed July 8, 2025.
  17. Lutathera (prescribing information). Novartis; 2024. https://www.lutathera.com. Accessed July 8, 2025.
  18. Pluvicto (prescribing information). Novartis; 2025. https://www.pluvicto.com. Accessed July 8, 2025.
  19. Metastron (prescribing information). GE Healthcare; 2013. http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=020134. Accessed July 8, 2025.
  20. Metastron (prescribing information). Bayer; 2019. https://www.xofigo.com. Accessed July 8, 2025.
  21. Patient preparation for nuclear medicine procedures involving injections. Society of Nuclear Medicine & Molecular Imaging. https://snmmi.org/Patients/Patients/Nuclear-Medicine-101.aspx. Accessed June 25, 2025.
  22. Renal (kidney) scintigraphy. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/renal. Accessed June 25, 2025.
  23. Radioactive iodine (I-131) therapy for hyperthyroidism. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/radioiodine. Accessed June 25, 2025.
  24. Hicon (prescribing information). Jubilant Radiopharma; 2021. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021305. Accessed July 8, 2025.
  25. Nuclear medicine and radiation safety. Society of Nuclear Medicine & Molecular Imaging. https://snmmi.org/Patients/Patients/Fact-Sheets/Fact-Sheet--Nuclear-Medicine-and-Radiation-Safety.aspx. Accessed June 25, 2025.
  26. Cardiac nuclear medicine. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/cardinuclear. Accessed June 25, 2025.
  27. Health Education & Content Services. Radioactive iodine (I-131). Mayo Clinic; 2018.
  28. Health Education & Content Services. Prostate-specific membrane antigen therapy: For the treatment of prostate cancer. Mayo Clinic; 2023.
  29. Health Education & Content Services. Radioligand therapy for somatostatin-positive tumors. Mayo Clinic; 2024.
  30. Radioimmunotherapy (RIT). RadiologyInfo.org. https://www.radiologyinfo.org/en/info/radio-immuno. Accessed June 25, 2025.
  31. Calais J, et al. Best patient care practices for administering PSMA-targeted radiopharmaceutical therapy. Journal of Nuclear Medicine. 2024; doi:10.2967/jnumed.124.268363.
  32. All about your radiology report: What to know. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/all-about-your-radiology-report. Accessed July 9, 2025.
  33. Catalano OA, ed. Radiopharmaceuticals and contrast agents. In: Clinical PET/MRI. Elsevier; 2023. https://www.clinicalkey.com. Accessed May 13, 2025.
  34. Harris KM. Allscripts EPSi. Mayo Clinic. April 23, 2024.
  35. Choline C 11 injection (approval letter). New Drug Application 203155. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203155. Accessed April 4, 2025.
  36. Become a comprehensive radiopharmaceutical therapy center of excellence. Society of Nuclear Medicine and Molecular Imaging. https://snmmi.org/Web/Clinical-Practice/Radiopharmaceutical-Therapy-Centers-of-Excellence/Become-a-Comprehensive-Radiopharmaceutical-Therapy-Center-of-Excellence.aspx. Accessed July 29, 2025.
  37. Medical review (expert opinion). Mayo Clinic. July 26, 2025.

相关

Mayo Clinic 新闻

Radiopharmaceuticals